title: Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus.
authors.forename: Nish
authors.initials: N
authors.lastname: Chaturvedi
authors.forename: Rudy
authors.initials: R
authors.lastname: Bilous
authors.forename: Anne Katrin
authors.initials: AK
authors.lastname: Sjolie
authors.forename: Ron
authors.initials: R
authors.lastname: Klein
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D003930:Diabetic Retinopathy / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012171:Retinal Vessels / Q000473:pathology
chemical_list: D000959:Antihypertensive Agents; D001786:Blood Glucose; D007004:Hypoglycemic Agents